Cargando…
Challenges in operationalising clinical trials in India during the COVID-19 pandemic
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694703/ https://www.ncbi.nlm.nih.gov/pubmed/34953516 http://dx.doi.org/10.1016/S2214-109X(21)00546-5 |
_version_ | 1784619413966684160 |
---|---|
author | Bassi, Abhinav Arfin, Sumaiya Joshi, Rohina Bathla, Nikita Hammond, Naomi E Rajbhandari, Dorrilyn Tirupakuzhi Vijayaraghavan, Bharath Kumar Venkatesh, Balasubramanian Jha, Vivekanand |
author_facet | Bassi, Abhinav Arfin, Sumaiya Joshi, Rohina Bathla, Nikita Hammond, Naomi E Rajbhandari, Dorrilyn Tirupakuzhi Vijayaraghavan, Bharath Kumar Venkatesh, Balasubramanian Jha, Vivekanand |
author_sort | Bassi, Abhinav |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8694703 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author(s). Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86947032021-12-23 Challenges in operationalising clinical trials in India during the COVID-19 pandemic Bassi, Abhinav Arfin, Sumaiya Joshi, Rohina Bathla, Nikita Hammond, Naomi E Rajbhandari, Dorrilyn Tirupakuzhi Vijayaraghavan, Bharath Kumar Venkatesh, Balasubramanian Jha, Vivekanand Lancet Glob Health Comment The Author(s). Published by Elsevier Ltd. 2022-03 2021-12-22 /pmc/articles/PMC8694703/ /pubmed/34953516 http://dx.doi.org/10.1016/S2214-109X(21)00546-5 Text en © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Comment Bassi, Abhinav Arfin, Sumaiya Joshi, Rohina Bathla, Nikita Hammond, Naomi E Rajbhandari, Dorrilyn Tirupakuzhi Vijayaraghavan, Bharath Kumar Venkatesh, Balasubramanian Jha, Vivekanand Challenges in operationalising clinical trials in India during the COVID-19 pandemic |
title | Challenges in operationalising clinical trials in India during the COVID-19 pandemic |
title_full | Challenges in operationalising clinical trials in India during the COVID-19 pandemic |
title_fullStr | Challenges in operationalising clinical trials in India during the COVID-19 pandemic |
title_full_unstemmed | Challenges in operationalising clinical trials in India during the COVID-19 pandemic |
title_short | Challenges in operationalising clinical trials in India during the COVID-19 pandemic |
title_sort | challenges in operationalising clinical trials in india during the covid-19 pandemic |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694703/ https://www.ncbi.nlm.nih.gov/pubmed/34953516 http://dx.doi.org/10.1016/S2214-109X(21)00546-5 |
work_keys_str_mv | AT bassiabhinav challengesinoperationalisingclinicaltrialsinindiaduringthecovid19pandemic AT arfinsumaiya challengesinoperationalisingclinicaltrialsinindiaduringthecovid19pandemic AT joshirohina challengesinoperationalisingclinicaltrialsinindiaduringthecovid19pandemic AT bathlanikita challengesinoperationalisingclinicaltrialsinindiaduringthecovid19pandemic AT hammondnaomie challengesinoperationalisingclinicaltrialsinindiaduringthecovid19pandemic AT rajbhandaridorrilyn challengesinoperationalisingclinicaltrialsinindiaduringthecovid19pandemic AT tirupakuzhivijayaraghavanbharathkumar challengesinoperationalisingclinicaltrialsinindiaduringthecovid19pandemic AT venkateshbalasubramanian challengesinoperationalisingclinicaltrialsinindiaduringthecovid19pandemic AT jhavivekanand challengesinoperationalisingclinicaltrialsinindiaduringthecovid19pandemic |